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Abstract
Mycoplasma hominis is an opportunistic human mycoplasma. Two other pathogenic human species, M. genitalium and
Ureaplasma parvum, reside within the same natural niche as M. hominis: the urogenital tract. These three species have
overlapping, but distinct, pathogenic roles. They have minimal genomes and, thus, reduced metabolic capabilities
characterized by distinct energy-generating pathways. Analysis of the M. hominis PG21 genome sequence revealed that it is
the second smallest genome among self-replicating free living organisms (665,445 bp, 537 coding sequences (CDSs)). Five
clusters of genes were predicted to have undergone horizontal gene transfer (HGT) between M. hominis and the
phylogenetically distant U. parvum species. We reconstructed M. hominis metabolic pathways from the predicted genes,
with particular emphasis on energy-generating pathways. The Embden–Meyerhoff–Parnas pathway was incomplete, with a
single enzyme absent. We identified the three proteins constituting the arginine dihydrolase pathway. This pathway was
found essential to promote growth in vivo. The predicted presence of dimethylarginine dimethylaminohydrolase suggested
that arginine catabolism is more complex than initially described. This enzyme may have been acquired by HGT from non-
mollicute bacteria. Comparison of the three minimal mollicute genomes showed that 247 CDSs were common to all three
genomes, whereas 220 CDSs were specific to M. hominis, 172 CDSs were specific to M. genitalium, and 280 CDSs were
specific to U. parvum. Within these species-specific genes, two major sets of genes could be identified: one including genes
involved in various energy-generating pathways, depending on the energy source used (glucose, urea, or arginine) and
another involved in cytadherence and virulence. Therefore, a minimal mycoplasma cell, not including cytadherence and
virulence-related genes, could be envisaged containing a core genome (247 genes), plus a set of genes required for
providing energy. For M. hominis, this set would include 247+9 genes, resulting in a theoretical minimal genome of 256
genes.
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Introduction
Mycoplasma hominis is an opportunistic human mycoplasma
species which resides, as a commensal, in the lower urogenital
tract. However, it can also cause pelvic inflammatory disease and
postpartum or postabortion fevers, and has been associated with
bacterial vaginosis [1]. In newborns, it can cause pneumonia,
meningitis or abscesses. It has also been implicated in extragenital
infections, especially in immunocompromised patients.
Two other mollicute species, M. genitalium and Ureaplasma
urealyticum, the latter having been recently separated into two
species U. parvum and U. urealyticum [2], have established
pathogenic roles in humans and reside within the same natural
niche, the urogenital tract, as M. hominis. However, these species
have overlapping but distinct pathogenic roles [1]. M. genitalium
and Ureaplasma spp., but not M. hominis, are involved in male
urethritis. M. genitalium is also the only mycoplasmal species
involved in cervicitis, whereas Ureaplasma spp. are significantly
associated with prematurity, low birth weight and chronic lung
disease in infants [1]. These three urogenital species belong to two
different phylogenetic groups within the class Mollicutes: M.
genitalium and Ureaplasma spp. belong to the Pneumoniae group
and M. hominis belongs to the Hominis group. They possess the
smallest genomes among self-replicating free living organisms. The
M. genitalium genome is the smallest of these, comprising 580 Kbp,
with a capacity to encode only 482 genes [3]. The minimal nature
of the M. genitalium genome triggered particular interest in this
organism and several studies have addressed the concept of a
minimal cell [4–6]. More recent studies have attempted to
reconstruct its genome by chemical synthesis [7,8], with a view
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laboratorium [9]. The genome of M. hominis is slightly larger than
that of M. genitalium, with pulsed-field gel electrophoresis revealing
a chromosome size of 696 Kbp [10]. The sequenced genome of U.
parvum (previously called U. urealyticum serovar 3) is the largest of
the three species, encompassing 751 Kbp [11]. These three species
can therefore be considered as minimal bacterial cell prototypes
with reduced metabolic abilities. Interestingly, in addition to their
distinct pathogenic roles, they also have different energy-
generating pathways. M. genitalium is a glycolytic species, whereas
M. hominis and Ureaplasma spp. are both nonglycolytic species,
producing energy through arginine degradation or urea hydrolysis,
respectively [12]. Thus, during the evolution of mollicutes, these
three human pathogens have undergone substantial genome
reduction resulting in minimal, but distinct, metabolic mecha-
nisms.
Of all the mycoplasma species with a known pathogenic role in
humans, M. hominis was the only one that had not been sequenced.
We therefore sequenced the whole genome of the M. hominis PG21
type strain. We examined its energy-generating pathways and
investigated the essential role of its arginine dihydrolase pathway in
vivo. To provide further insight into the composition of
hypothetical minimal gene sets and of the associated energy-
generating pathways, we carried out whole genome comparisons
of the three pathogenic mycoplasmas, M. hominis, M. genitalium and
U. parvum, sharing the same urogenital niche and displaying near
minimal genomes. This analysis resulted in the identification of a
set of shared genes representing the core genome. Other genes
include those that are involved in the energy-yielding pathways
specific to each mollicute and those that play a role in the
interaction with the host, such as cytadherence and virulence.
Results
General features of the M. hominis genome
The general features of the M. hominis PG21 genome and their
comparison with those of M. genitalium G37 and U. parvum serovar
3 are shown in Table 1. The M. hominis PG21 genome is a single,
circular chromosome of 665,445 bp with an overall G+C content
of 27.1%. It contains 537 putative coding DNA sequences (CDSs),
representing a 89.8% gene density, and 14 pseudogenes were
found. Function could be predicted for 345 of the CDSs, whereas
86 were conserved hypothetical proteins (CHP) and 106 were
hypothetical proteins (HP). A minimal but complete set of 33
tRNA genes was identified. The M. hominis genome contained two
copies of rRNA genes, as previously described [10]. The 5S rRNA
genes are not located within the 16S–23S rRNA operons, as is the
case in M. arthritidis [13], the phylogenetically closest genome-
sequenced species. No insertion sequence, transposon, or endog-
enous plasmid was found in the genome.
A set of 43 lipoproteins was predicted from the M. hominis
genome, including three ABC transporter substrate-binding
proteins (MHO_3610, MHO_3620, MHO_1510), two predicted
nucleases (MHO_0660, MHO_0730) and one predicted peptidase
(MHO_4970). Interestingly, the lipobox sequence, located up-
Author Summary
Mycoplasma hominis, M. genitalium, and Ureaplasma
parvum are human pathogenic bacteria that colonize the
urogenital tract. They have minimal genomes, and thus
have a minimal metabolic capacity. However, they have
distinct energy-generating pathways and distinct patho-
genic roles. We compared the genomes of these three
human pathogen minimal species, providing further
insight into the composition of hypothetical minimal gene
sets needed for life. To this end, we sequenced the whole
M. hominis genome and reconstructed its energy-gener-
ating pathways from gene predictions. Its unusual major
energy-producing pathway through arginine hydrolysis
was confirmed in both genome analyses and in vivo assays.
Our findings suggest that M. hominis and U. parvum
underwent genetic exchange, probably while sharing a
common host. We proposed a set of genes likely to
represent a minimal genome. For M. hominis, this minimal
genome, not including cytadherence and virulence-related
genes, can be defined comprising the 247 genes shared by
the three minimal genital mollicutes, combined with a set
of nine genes needed for energy production for cell
metabolism. This study provides insight for the synthesis
of artificial genomes.
Table 1. Comparison of general features of the M. hominis
genome with those of M. genitalium G37 (ATCC 33530) and U.
parvum serovar 3 (ATCC 700970).
Features
a
M. hominis
PG21
M. genitalium
G37
U. parvum
serovar 3
Genome size (bp) 665,445 580,074 751,719
GC content of genome (%) 27.1 31.7 25.5
Gene density (%) 89.8 91.2 91.3
Total number of CDS 537 482 614
Hypothetical proteins 106 2 182
Conserved hypothetical proteins 86 164 107
CDSs with predicted fonction 345 316 325
Pseudogenes 14
b 5
c 0
c
Average protein length (aa) 369 363 371
Proteins with predicted
MW.300 kDa
2 02
Predicted lipoproteins 43 18
d 37
d
rRNA sets 2
e 12
tRNA 33 36 30
Start codon usage (%)
AUG 95.1 88.5 92.5
UUG 3.0 4.1 3.0
GUG 1.7 7.4 4.5
Other 0.2 00
Stop codon usage (%)
UAA 83 72 85
UAG 16 27 14
Tryptophan codon usage (%)
UGA 87 64 87
UGG 13 36 13
aPreviously published data [3,11], not including average protein length, the
high molecular weight protein prediction, and start and stop codon usage,
obtained from the MolliGen website (http://cbi.labri.fr/outils/molligen).
bEach part of a pseudogene is counted.
cData from the Integrated Microbial Genomes website (http://imgweb.jgi-psf.
org/cgi-bin/w/main.cgi?page=home).
dLipoprotein number based on genome annotation.
eTwo sets of 16S–23S rRNA genes and two single 5S rRNA genes elsewhere in
the genome.
CDS, coding sequence; ND, not determined; MW, molecular weight.
doi:10.1371/journal.pgen.1000677.t001
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predicted lipoproteins, MHO_1730, MHO_2100, MHO_2340,
MHO_2440, MHO_2620, with the consensus motif PLVAAGC
present in all of them. In contrast to these conserved regions, the
other regions of the proteins were very different in length and
sequence, suggesting their rapid and divergent evolution from a
common ancestral gene.
We assigned the origin of replication based on sequence
homology with the M. arthritidis genome [13] and several other
mycoplasmas [14] for which this oriC was experimentally
demonstrated to be functional. We did not detect any significant
inversion in the GC skew for M. hominis. The synteny rnpA R rpmH
R dnaA R dnaN was present, as previously observed in M.
arthritidis, M. capricolum subsp. capricolum and M. mycoides subsp.
mycoides SC [13–15]. Two identical putative DnaA boxes
(TTATTAACA) were found in the intergenic region upstream
of the dnaA gene, but none between dnaA and dnaN. These boxes
showed sequence identity at seven of the nine positions of the
Escherichia coli consensus sequence TTATCCACA [16]. They were
also identical to the unique DnaA box upstream from the dnaA
gene in M. mobile [17] and M. arthritidis [13], both of which belong
to the same phylogenetic group as M. hominis.
Horizontal gene transfers from mollicutes sharing the
same ecological niche
We identified genes that may have been exchanged through
horizontal gene transfer (HGT), by searching for M. hominis CDSs
that show a best Blast hit (BBH) in species other than those
belonging to the Hominis phylogenetic group. From the 537 CDSs
predicted from the M. hominis chromosome, 59 had a BBH in a
mollicute belonging to the phylogenetic groups Pneumoniae,
Spiroplasma or Phytoplasma and 12 had a non-mollicute BBH.
We then examined each of the candidate CDSs for potential
HGT, using phylogenetic reconstructions and synteny analysis.
Five CDSs seemed to be likely candidates for HGT between M.
hominis and non-mollicute bacteria (Table 2). Their closest
homologs were found in commensal or pathogenic bacteria
previously identified in humans, suggesting a possible scenario
for gene exchange. One of the five CDSs (MHO_2540) was of
particular interest because it encoded a putative N-dimethylargi-
nine dimethylaminohydrolase (DDAH), an enzyme linked to the
arginine pathway (see below). Among other mollicutes, only one
clear orthologous gene was predicted in the phylogenetically
closest related M. arthritidis (85% similarity), but the deduced
protein was truncated in N-terminal by a third of its length. A
putative DDAH was also proposed in M. penetrans (MYPE1510)
but it appeared very different from MHO_2540 (45% similarity)
and from other bacterial orthologs, suggesting a specific evolution
and/or origin. Except in M. arthritidis, closest homologs of
MHO_2540 were found in non-mollicute bacteria including the
human pathogens Eggerthella lenta (76% similarity), Atopobium vaginae
(72% similarity) and Pseudomonas aeruginosa (71% similarity).
Although phylogenetic reconstructions remained unclear, this
suggests that MHO_2540 and its truncated ortholog in M.
arthritidis might have a non-mollicute origin.
Most of the 59 CDSs showing BBHs in mollicutes belonging to
groups other than the Hominis phylogenetic group also had closely
related homologs within the Hominis group and phylogenetic
reconstructions did not allow clarification of their origin.
Nevertheless, features indicative of HGT were found for six genes
or groups of genes. In particular, MHO_0360 encoded a predicted
type II cytosine-specific methyltransferase, for which the only
homolog in mollicutes was found in M. mycoides subsp. mycoides SC
(Table 2). Closely related homologs were also identified in other
bacteria, such as Clostridium and Streptococcus spp., with more than
80% amino-acid sequence similarity. This suggested that a type II
restriction/modification system may have been exchanged be-
tween these bacteria.
Five clusters of genes from the M. hominis genome were found to
have their closest homologs in the urogenital pathogen U. parvum,
which belongs to the phylogenetically distant Pneumoniae group
(Table 2). The first cluster included MHO_0120 to MHO_0140,
encoding a predicted type III restriction/modification system
(Figure S1). Closely related homologs were found in U. parvum, M.
penetrans and several species of the Hominis group. Phylogenetic
reconstruction, inferred from restriction enzyme sequences,
associated the M. hominis (MHO_0120) and U. parvum (UU476)
homologs with a bootstrap support value of 100%, suggesting that
HGT occurred between the two species. In both species, the
modification methylase-encoding gene was split into two by a
frameshift that occurred within tracts of repeated nucleotides. In
MHO_0130/MHO_0140, a simple deletion of one nucleotide
within a tract of 11 guanosines restored the complete ORF,
suggesting that the expression of the encoded methylase may be
switched on and off by a phase variation mechanism, similar to
that previously described for another type III restriction/
modification system in M. pulmonis [18].
The two gene clusters, MHO_5210 to MHO_5240 and
MHO_3220 to MHO_3250, encoded predicted type I restric-
tion/modification systems (Figure S2). The first cluster contained
full-length hsdR, hsdS (2 genes) and hsdM genes and encoded the
components of the system. In contrast, the second cluster only
contained the two hsdS genes and an hsdM gene that was split into
two by a frameshift mutation. Nucleotide sequences of the genes
within the two clusters were nearly identical, indicative of a
probable duplication event. Phylogenetic trees inferred from the
protein sequences of the M. hominis R and M subunits showed a
close relationship with their homologs in U. parvum (UU095 to
UU100).
A fourth cluster included CDSs MHO_2520 and MHO_2530,
two fragments of a transposase-encoding gene from an IS1138
element (Figure S3). Phylogenetic analysis demonstrated a stronger
relationship between this gene and its fragmented homolog in U.
parvum (UU374/UU373/UU372) than with any other transposase
gene. Moreover, sequence alignments revealed more than 90%
similarity for the predicted proteins and extensive regions in which
the nucleotide sequences were strictly identical. These data
strongly suggest recent exchange of this mobile element between
the two species.
The fifth group of genes that may have been exchanged with U.
parvum encoded seven conserved hypothetical proteins and two
additional ATP synthase subunits (MHO_3120 to MHO_3200)
(Figure S4). As described for the other clusters, this potential gene
exchange was deduced from protein-inferred phylogenetic trees
and conservation of gene order. The seven CHPs were predicted
to include one lipoprotein and three proteins with transmembrane
segments, suggesting a location at the cell surface.
It should be noted that, whereas five clusters of genes may have
been exchanged with the U. parvum, no HGT was predicted with
the urogenital pathogen M. genitalium, or with M. penetrans, another
human mollicute reported in the urogenital tract [1].
Comparative analysis of the M. hominis, M. genitalium,
and U. parvum genomes
The M. hominis genome was compared to the genomes of M.
genitalium and U. parvum, the two other urogenital mollicute species
that infect humans. Orthology relationships between the three
genomes were computed using a bidirectional best hit method.
Mycoplasma Minimal Genomes
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M. hominis CDS Closest homolog
Mnemonic Predicted function
Accession
number or
mnemonic Species
%
Similarity
Highest
similarity
in Hominis
group % Comment
MHO_0350 Aminopeptidase C O69192 Listeria
monocytogenes
59 no
a contains motif COG3579, PepC,
aminopeptidase C
MHO_0930 Diadenosine 59590-P1,P4-
tetraphosphatepyrophosphohydrolase
(MutT/nudix family protein)
EDP68279 Carnobacterium sp. 66 no no homolog in mycoplasmas
MHO_1490 Conserved hypothetical protein Q48SX1 Streptococcus
pyogenes
66 no homologs in several firmicutes
from the microbiota
MHO_2540 N-dimethylarginine dimethylaminohydrolase ZP_03894500 Eggerthella
lenta
76 no
a predicted N-dimethylarginine
dimethylaminohydrolase in M.
penetrans,b u tv e r yd i f f e r e n t
from others
MHO_4710 Virulence-associated protein D O05728 Helicobacter
pylori
60 no
a contains motif VapD,
uncharacterized virulence-
associated protein D, no
homolog in mycoplasmas
MHO_0360 Cytosine-specific DNA-methyltransferase/Type
II site-specific deoxyribonuclease
MSC0216 M. mycoides subsp.
mycoides SC
83 47 Highly related orthologs in
Clostridium (83% similarity)
MHO_0120 Type III restriction enzyme UU476 U. parvum 71 57
MHO_0130 Pseudogene of Type III restriction-modification
system: methylase (part 2)
UU477 U. parvum 57 76 probable phase variation, split in
U. parvum, inferred by synteny
MHO_0140 Pseudogene of Type III restriction-modification
system: methylase (part 1)
UU478 U. parvum 76 73 probable phase variation, split in
U. parvum, inferred by synteny
MHO_2520 Pseudogene of transposase for insertion
sequence element IS1138, (part 1)
UU374 U. parvum 95 no truncated
MHO_2530 Pseudogene of transposase for insertion
sequence element IS1138, (part 2)
UU372 U. parvum 94 66 truncated
MHO_2560 Truncated integrase-recombinase protein UU372 U. parvum 96 67 truncated
MHO_3120 ATP synthase beta chain UU054 U. parvum 92 86
MHO_3130 ATP synthase alpha chain UU053 U. parvum 86 80
MHO_3140 Conserved hypothetical protein UU052 U. parvum 69 46 3 TMB
b predicted
MHO_3150 Conserved hypothetical protein UU051 U. parvum 68 57
MHO_3160 Conserved hypothetical protein UU050 U. parvum 82 69
MHO_3170 Conserved hypothetical protein UU049 U. parvum 69 61
MHO_3180 Conserved hypothetical protein UU048 U. parvum 72 51 12 TMB predicted
MHO_3190 Conserved hypothetical protein UU046 U. parvum 72 63 1 TMB predicted
MHO_3200 Conserved hypothetical protein, predicted
lipoprotein
UU045 U. parvum 65 54 predicted lipoprotein
MHO_3220 Type I restriction enzyme specificity protein UU096 U. parvum 56 46 split in U. parvum
MHO_3230 Type I restriction enzyme specificity protein UU099 U. parvum 45 43 truncated in U. parvum
MHO_3240 Pseudogene of Type I restriction enzyme M
protein (C-terminal part)
UU098 U. parvum 81 77 split in U. parvum
MHO_3250 Pseudogene of Type I restriction enzyme M
protein (N-terminal part)
UU098 U. parvum 75 81 split in U. parvum
MHO_5210 Type I restriction enzyme M protein UU098 U. parvum 74 80 split in U. parvum
MHO_5220 Type I restriction enzyme specificity protein UU096 U. parvum 62 46 split in U. parvum
MHO_5230 Type I restriction enzyme specificity protein UU099 U. parvum 89 50 truncated in U. parvum
MHO_5240 Type I restriction-modification system
endonuclease
UU095 U. parvum 65 70 inferred by synteny
aExcept in the phylogenetically closest related M. arthritidis.
bTMB, transmembrane segment.
doi:10.1371/journal.pgen.1000677.t002
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provided in Table S1. We found 247 CDSs common to all three
genomes, forming the core genome, and identified 220 CDSs
specific to M. hominis, 172 CDSs specific to M. genitalium and 280
CDSs specific to U. parvum. The M. hominis genome shared 24
CDSs only with M. genitalium and 46 CDSs only with U. parvum,
whereas 41 CDSs found in both M. genitalium and U. parvum were
not found in the M. hominis genome.
The M. hominis, M. genitalium, and U. parvum genomes
share a core set of 247 genes, many of which are
essential
The 247 orthologous genes shared by the three mollicutes
encoded proteins involved in major cellular functions, including
DNA metabolism, protein synthesis, nucleotide synthesis, trans-
port and binding of substrates, and fatty acid and phospholipid
metabolism (Table S1). Interestingly, these core genes were found
to encode only a few cell envelope proteins: the putative
membrane conserved hypothetical proteins MHO_3900,
MHO_4290 and MHO_4370. Most of these 247 shared genes
are likely to be essential, consistent with findings from an extensive
gene inactivation study in M. genitalium [6]. Indeed, 213 of the 247
genes (86.2%) could not be inactivated by transposon mutagenesis.
Moreover, only 35 of these 213 genes could be inactivated in the
two phylogenetically-related species M. arthritidis [13] or M.
pulmonis [19] (Table S2). Among the 247 shared genes, 217 were
also predicted in the genomes of other human and animal
mycoplasmas (Table S2). Most of the 30 remaining genes were
only missing in one or two species, suggesting a recent loss. Finally,
a total of 160 genes that could not be inactivated were shared by
all available mycoplasma genomes.
Genes related to cytadherence and virulence are mainly
species-specific
Many of the species-specific genes were associated with
cytadherence and virulence (Figure 1B). Genes found specifically
in M. hominis coded for: (i) the lipoprotein P120 (MHO_3660) and
the protein P120’ (MHO_3800), which are M. hominis-specific
surface-exposed proteins displaying antigenic variation [20,21]; (ii)
the Vaa surface lipoprotein adhesin (MHO_3470), which is an
abundant surface antigen displaying high-frequency phase and size
variation and which is involved in adhesion to host cells [21,22]; (iii)
theP60and P80 proteins(MHO_3490,MHO_3500),which form a
membrane complex at the surface and are encoded by an operon
[23]; (iv) the P75 lipoprotein (MHO_3720), which is also present at
the surface of M. hominis [24], and the P75-related lipoprotein
(MHO_3100), which shows 37.9% similarity with the P75 protein.
CDSs specific to M. hominis also included OppA (MHO_1510), an
oligopeptide permease substrate-binding protein. OppA is a
multifunctional lipoprotein involved in cytadherence, but is
probably also the main ecto-ATPase at the surface of the M. hominis
cell[25,26].ArecentstudyshowedthatitinducedATPreleasefrom
cells, resulting in apoptosis, thus suggesting its role as a M. hominis
virulence factor [27]. Lmp1 (MHO_0530) and Lmp3
(MHO_1640), two related surface membrane proteins [28], and
six additional Lmp-related proteins (MHO_0540, MHO_3070,
MHO_3110, MHO_3730, MHO_4280 and MHO_4920), were
also found in this group of M. hominis-specific genes. The eight Lmp
proteins represent a family of proteins characterized by a predicted
N-terminal transmembrane helix and several repeat sequences. In
particular, using the MEME method, we identified a 57 amino-acid
motif, [QK][QK]L[DKQ][DN]LI[DK]S[NQE][DE][AG][KQ]-
[DKN][VI]D[KT][SQ]K[EA][TN][QDN][IS][LF][NQ]N[TN]N-
[LVI][DT][AG][SKN][SD][LT][IT][KD][DQ]I[EKV][SN][KA]-
[TI][KN][TE]I[EK][DK]A[IT][QEK][SD]L[TQ]K[KL]I[ND],
repeated between one and 15 times, in all proteins except
MHO_0530 and MHO_4280.
Similarly, genes specific to M. genitalium and U. parvum genomes
included several CDSs associated with cytadherence and virulence
(Table S1, Figure 1B). The 172 M. genitalium specific CDSs
included genes encoding the adhesin MgPa (MG191), the MgpC
protein (MG 192), the adhesin P32 (MG318), the protein P200
(MG386) and the cytadherence accessory proteins Hmw1, Hmw2
and Hmw3 (MG218, MG312, MG317). Of the 280 CDSs specific
to U. parvum, genes associated with cytadherence and virulence
included those encoding the MBA protein (UU375) — a major
antigen recognized during infection of humans — and the five
MBA N-terminal paralogs (UU172, UU189, UU483, UU487,
UU526). Genes encoding eight iron transporters (UU022, UU023,
UU025, UU357, UU358, UU400, UU515, UU516), nine putative
ABC substrate-binding protein-iron (UU024, UU027, UU028,
UU069, UU071, UU359, UU360, UU401, UU517) and two
hemin transporters (UU070, UU399) were also found in the U.
parvum genome, but not in M. hominis or M. genitalium. It should be
noted that the virulence-related gene msrA, encoding the peptide
methionine sulfoxide reductase, was found in both M. genitalium
(MG408) and U. parvum (UU289), but not in M. hominis.I nM.
genitalium, inactivation of the msrA gene reduces adherence and
abolishes virulence [29].
M. hominis, M. genitalium, and U. parvum display marked
species differences in their reduced energetic
metabolism
Several species-specific genes were involved in the major
energy-generating metabolic pathways. In M. genitalium, which is
a glycolytic species, several genes encoding components of the
carbohydrate, pyruvate and glycerol metabolic pathways were
found among its 172 specific CDSs, including carbohydrate
transporter genes (Table S1). Indeed, the 1-phosphofructokinase-
encoding gene fruK (MG063), fruA (MG062) and pstG (MG069)
genes of the fructose and glucose phosphoenolpyruvate-dependent
sugar phosphotransferase transport system (PTS) were found
specifically in M. genitalium. Moreover, the four genes encoding the
pyruvate dehydrogenase complex, pdhA (MG274), pdhB (MG273),
pdhC (MG272) and pdhD (MG271), the glycerol kinase gene gplK
(MG038) and the glycerol uptake facilitator gene glpF (MG033)
were predicted in the M. genitalium genome only, and not in the M.
hominis or U. parvum genomes. In U. parvum, which generates ATP
through urea hydrolysis, the seven components of the urease
complex (UU428 to UU434), the ammonium transporters Amt-1
and Amt-2 (UU218, UU219) and the atypical delta subunits of the
FoF1-ATPase (UU133, UU134) probably involved in this unique
energy production pathway [11], were found among the 280
CDSs that were absent from M. hominis and M. genitalium (Table
S1).
In M. hominis, a nonglycolytic species, all the genes coding for all
enzymes of the Embden-Meyerhoff-Parnas (EMP) pathway were
present except 6-phosphofructokinase (Figure 2). The nonglyco-
lytic U. parvum, however, had the 6-phosphofructokinase gene, but
did not have the gene encoding glucose-6-phosphate isomerase,
which catalyzes the step leading to fructose 6-phosphate
production [11] (Figure 2). The set of genes coding for enzymes
in the pentose phosphate pathway was incomplete in M. hominis,
with the absence of genes encoding glucose-6-phosphate dehy-
drogenase and 6-phosphogluconate dehydrogenase. These genes
were also absent from M. genitalium and U. parvum. The genes
coding for other enzymes involved in carbohydrate metabolism
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PLoS Genetics | www.plosgenetics.org 5 October 2009 | Volume 5 | Issue 10 | e1000677Figure 1. Comparative analysis of the genomes of three minimal mollicutes affecting humans. (A) Number of specific and shared CDSs
for the genomes of M. hominis PG21, M. genitalium G37, and U. parvum serovar 3. (B) Focus on known species-specific proteins involved in
cytadherence/virulence and energy-generating pathways. LMP, large membrane protein; PTS, phosphoenolpyruvate phosphotransferase system;
HGT, horizontal gene transfer; UP, U. parvum; MH, M. hominis; MG, M. genitalium.
doi:10.1371/journal.pgen.1000677.g001
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PLoS Genetics | www.plosgenetics.org 6 October 2009 | Volume 5 | Issue 10 | e1000677Figure 2. Comparison of carbohydrate- and arginine-metabolism pathways and transporters encoded by M. hominis PG21, M.
genitalium G37, and U. parvum serovar 3. Metabolic products are shown in black. Putative proteins present in M. hominis are shown in green;
proteins absent from M. hominis are shown in red. ‘‘MG’’ in purple boxes indicates that the gene encoding the corresponding protein is present in the
M. genitalium G37 genome. ‘‘UP’’ in blue boxes means that the gene encoding the corresponding protein is present in the U. parvum genome.
Transporters are colored according to their substrates: yellow, cations; green, anions and amino-acids; orange, carbohydrates; purple, multidrug and
metabolic end product efflux. Arrows indicate the direction of substrate transport.
doi:10.1371/journal.pgen.1000677.g002
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phosphofructokinase, which is involved in fructose metabolism,
and the pyruvate dehydrogenase complex, as mentioned above
[11,30]. Thus, a complete set of genes encoding components of the
EMP pathway was present in M. genitalium [3,30], which is able to
generate ATP through glucose hydrolysis, whereas the M. hominis
and U. parvum genomes each lacked a single gene encoding a
component of the EMP pathway. It should also be noted that M.
hominis, like U. parvum [11], does not seem to possess a complete
phophoenolpyruvate phosphotransferase system (PTS), as only a
putative energy-coupling protein HPr (MHO_0590) and the
component B of the enzyme II complex (MHO_1070) were
predicted. In contrast, the glycolytic M. genitalium possessed two
complete glucose and fructose PTS. Finally, the two genes
encoding enzymes of the acetate kinase–phosphotransacetylase
pathway, which is generally fully reversible (acetate+ATP+-
CoA«acetyl-CoA+ADP+Pi) in bacteria, were present in M.
genitalium and U. parvum; but the phosphotransacetylase gene was
absent from the M. hominis genome (Figure 2, Table S1).
Interestingly, glycerol 3-phosphate dehydrogenase (gpsA,
MHO_1690) was present in both M. hominis and U. parvum. This
enzyme could lead to glyceraldehyde 3-phosphate production via
the second part of the EMP pathway involving triosephosphate
isomerase (Figure 2).
In M. hominis PG21, the three proteins constituting the arginine
dihydrolase pathway (Figure 2) — arginine deiminase (ADI) (arcA,
MHO_0690), ornithine carbamoyltransferase (arcB, MHO_0640)
and carbamate kinase (arcC, MHO_0630) — were found to be
specific among the three species discussed here. Moreover, a
putative dimethylarginine dimethylaminohydrolase (DDAH,
MHO_2540) was predicted in M. hominis but not in U. parvum
and M. genitalium.I nP. aeruginosa, DDAH (EC 3.5.3.18) catalyzes
the conversion of the N
v-alkylated arginine residues to citrulline.
A more detailed overview of the M. hominis energy-generating
pathway was obtained by searching for specific transporter genes
in the genome. The results are graphically displayed in Figure 2. A
putative arginine transporter, MHO_5040, containing 12 trans-
membrane domains was identified as a homolog of the amino-acid
permease MYPE6110, a protein which is encoded immediately
downstream from the arginine dihydrolase pathway cluster,
arcABC, in the M. penetrans genome [31], another arginine-utilizing
mycoplasma. However, in M. hominis, MHO_5040 was not located
in close proximity to the arcABC cluster. In addition, it should be
noted that no ammonia/ammonium transporters was identified in
the M. hominis genome.
To further determine the major energy-generating pathway in
M. hominis, we studied the growth of M. hominis PG21 in the
presence of arginine and arginine analogs (Table 3). In Hayflick
modified medium containing 2.5% horse serum, the M. hominis
culture reached 10
7 color changing units (CCU)/ml and the pH
increased from 7.0 to 7.2 after 48 hours. In medium supplemented
with 10 mM arginine, the titer after 48 hour growth was
unchanged, but the pH was higher than that observed without
addition of arginine, increasing from 7.0 to over 8.1. A total loss of
viability was observed after 120 hours under these conditions. The
effect on growth of adding horse serum was checked by inoculating
media with or without 2.5% horse serum. Growth was
independent of serum content in medium supplemented with
10 mM arginine. However, a non-supplemented medium lacking
horse serum was growth-limiting, with a 10-fold lower titer of
organisms after 48 hours (data not shown). Thus, the serum-
containing Hayflick modified medium supplied the cells with
nutrients that were necessary to reach a high cell titer after
48 hours. Furthermore, in the absence of horse serum, the
exogenously added arginine provided energy for cell growth. The
effect on growth of canavanine, an arginine analog that interferes
with the arginine uptake and metabolism was evaluated.
Canavanine is an ADI-specific competitive inhibitor [32] and its
incorporation into proteins in bacterial species leads to cell death
[33]. In the presence of 10 mM canavanine, the cell concentration
remained constant at 10
5 CCU/ml over 120 hours. Addition of
23 mM arginine at 48 hours was sufficient to displace the
competitive inhibitor and restore growth (Table 3). Canavanine
suppressed the cell growth but did not trigger the M. hominis death
within 120 hours. Thus, while a possible incorporation of
canavanine into proteins cannot be totally ruled out, the
bacteriostatic effect of canavanine was most probably due to its
inhibitory effect on ADI. These data suggest that the ADI pathway
was required for initiation of growth in M. hominis. Finally, to test
whether asymmetric N
v,N
v-dimethyl-L-arginine (ADMA) could
be used as a substrate by DDAH and could serve as an energy
source for protein synthesis in M. hominis, growth was evaluated in
the presence of ADMA with ADI activity suppressed by
canavanine. The maximum concentration of ADMA that could
be assessed was 0.5 mM, because of the poor solubility and
dissolution rate of the arginine analog in aqueous solutions. Under
these conditions, in presence of 2.5% horse serum in the medium
(Table 3), as well in medium lacking horse serum, no growth was
detected after 48 hours.
Discussion
In this study, we first sequenced, annotated and analyzed the
genome of M. hominis PG21. Our analyses suggested the
occurrence of HGT between M. hominis and U parvum. Indeed,
five clusters of genes from the M. hominis genome were found to
have their closest homolog in U. parvum, which belongs to the
phylogenetically distant Pneumoniae group. These mollicutes
share the same urogenital niche, providing a potential explanation
for the predicted HGT. Phylogenomic studies have recently
reported the occurrence of HGT among animal mycoplasmas
sharing the same host. Indeed, 18% of the M. agalactiae genome has
undergone HGT with other pathogenic, ruminant mycoplasmas
from the phylogenetically distant Mycoides cluster [34]. In M.
hominis, the potential advantages of these events remain unclear.
Table 3. Growth of M. hominis PG21 in the presence of
arginine and arginine analogs.
M. hominis in basal mediuma
supplemented with: Growth in CCU/ml
b (pH)
t=0 t=48 h t=120 h
No supplement 10
5 (7.0) 10
7 (7.2) 10
6 (7.4)
Arginine (10 mM) 10
5 (7.0) 10
7 (8.1) 0 (8.2)
No supplement + Arginine
(23 mM) at t=48 h
10
5 (7.0) 10
7 (7.2) 10
5 (7.9)
Canavanine (10 mM) 10
5 (7.0) 10
5 (6.7) 10
5 (6.8)
Canavanine (10 mM) at t=0
+ arginine (23 mM) at t=48 h
10
5 (7.0) 10
5 (6.7) 10
7 (7.2)
Canavanine (10 mM) +ADMA
c
(0.5 mM)
10
5 (7.0) 10
5 (6.9) ND
d
acontaining heart infusion broth, yeast extract and 2.5% horse serum.
bCCU/ml, color changing unit/ml.
cADMA, N
v,N
v-dimethyl-L-arginine.
dND: not determined.
doi:10.1371/journal.pgen.1000677.t003
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HGT (MHO_3120 to MHO_3200) contains four putative cell-
surface proteins that may be involved in the interaction between
the mycoplasma and its human host. This is the first report of
HGT among human mollicutes. We did not find any evidence of
HGT between M. hominis and M. genitalium,o rM. penetrans. M.
hominis and U. parvum are both frequent commensals of the human
urogenital tract and they are commonly detected together in
healthy individuals. In contrast, M. penetrans is very rarely detected
in the urogenital tract [1], and the commensal status of M.
genitalium, which has a low prevalence in the general population
[35], remains unclear. Overall, these data suggest that genome
reduction was not the only factor affecting the evolution of these
minimal organisms.
We also compared the whole genomes of the three human
pathogenic mycoplasmas. Two major sets of genes could be
identified among species-specific genes. The first group contained
genes involved in energy-generating mechanisms, with the second
group containing genes involved in cytadherence and virulence.
Thus, these three mycoplasma species have their own specific
genetic equipment underlying their pathogenic roles. We found
several CDSs specific to M. hominis. These included the genes
encoding P120, P120’, Vaa, LMP1 and LMP3, which have been
previously identified as surface proteins displaying size, sequence,
and antigenic variation [20–22,24–26,28], and six genes annotated
as LMP-related proteins. The large number of members of the
LMP-related protein group and the repetitions present in their
DNA sequences is likely to provide the basis for genetic variability,
potentially playing a significant role in determining the response to
host defense mechanisms. Parallels can be drawn with the multiple
complete or partial copies of the M. pneumoniae P1 adhesin gene
[36] or the M. genitalium mgpB adhesin gene [3] dispersed on the
chromosome, which serve as reservoirs to generate antigenic
variation and participate in host defense evasion [37,38].
Proteomic studies could be used to identify the LMP-related
proteins expressed in M. hominis to further elucidate the role of
LMPs. Size variation among these cell envelope proteins could
also explain the heterogeneity in genome size within the M. hominis
species. Indeed, genome size was previously estimated for 15
strains using pulsed-field gel electrophoresis, and was found to vary
by more than 15%, ranging from 696 to 825 Kbp [10]. It is likely
that there are a number of genes involved in M. hominis pathogenic
mechanisms that are yet to be described, so the characterization of
genes specific to M. hominis could help to identify unknown
adhesion or virulence factors. Indeed, such factors could be
searched for among the 220 M. hominis-specific CDSs, particularly
among the hypothetical proteins, although virulence factors may
also be shared with other mycoplasma species.
M. hominis has been described as a nonglycolytic species that
generates ATP through arginine hydrolysis [12,39], as previously
described for M. arthritidis, the mycoplasma most closely related to
it for which the genome sequence is also available [12]. The
question of whether arginine degradation was the sole or the major
energy-generating mechanism has been asked for more than 30
years. We thus analyzed the genomes of the three mycoplasmas for
their genes encoding enzymes involved in the energy generation
from carbohydrate metabolism. Analysis of the M. hominis genome
revealed that the gene sets of the pentose phosphate pathway and
of the glucose and fructose transport PTS were incomplete, as has
been observed for other sequenced glycolytic and nonglycolytic
mollicutes [30,39,40]. Furthermore, previous enzymatic activity
studies, reporting the absence of 6-phosphofructokinase activity,
from the EMP pathway, in seven different strains of M. hominis
were confirmed in silico by the lack of the corresponding gene [12].
Thus, as previously proposed for U. parvum [11,30], it is unlikely
that M. hominis metabolizes hexoses such as glucose or fructose.
The presence of a gene encoding glycerol 3-phosphate dehydro-
genase in M. hominis suggests that glycerol 3-phosphate may be
oxidized into dihydroxyacetone phosphate, which could then enter
glycolysis (Figure 2). This would require glycerol or glycerol 3-
phosphate to be efficiently imported into the cell. This transport
could be mediated by a specific ABC transporter for sn-glycerol
phosphate, putatively encoded by MHO_0740–0760. Indeed,
MHO_0740–0760 shows a BBH and conserved synteny with
genes encoding putative glycerol transporters in other mollicute
species, such as M. synoviae and M. pneumoniae [36,41]. Further
downstream in this pathway, energy is not generated through
oxidation of pyruvate to acetyl-CoA, since the genes coding for the
pyruvate dehydrogenase complex are absent from the M. hominis
genome (Figure 2). The reversible acetate kinase-phosphotransa-
cetylase pathway was predicted to be incomplete in M. hominis,
suggesting that the putative conversion of acetate into acetylpho-
sphate does not lead to generation of acetylCoA. Nevertheless, the
presence of the gene encoding acetate kinase (ackA, MHO_3840) is
particularly notable, given the possible role of this enzyme in ATP
generation in M. hominis [42]. Acetylphosphate may be produced
during the conversion of xylulose 5-phosphate to glyceraldehyde 3-
phosphate by phosphoketolase (MHO_3010), the gene for which is
in the M. hominis genome but is absent from the U. parvum and M.
genitalium genomes. The presence of several gaps in the M. hominis
glycolysis and pyruvate pathways supports the notion that these
energy-generating pathways have a low efficiency in this species.
Consistent with this, we observed that the growth of M. hominis in
Hayflick modified broth supplemented with glucose [43] led to
alkalinisation of the culture medium (data not shown). M. hominis
species-specific genes included a complete set of genes coding for
the enzymes of the arginine dihydrolase pathway, which can
generate energy in the form of ATP for growth. Considering that
alternative energy-yielding pathways have been demonstrated for
several arginine-utilizing mollicutes [44,45], it remains unclear
whether the ATP produced by arginine breakdown can satisfy all
M. hominis growth requirements. Arginine is considered an
essential nutrient for initiation of growth of M. hominis [46].
However, the lack of correlation between CO2 production, cell
growth and ADI activity, as well as the delayed induction of ADI
relative to the cell cycle, led Fenske and Kenny [47] to suggest that
M. hominis used the arginine pathway only as an alternative energy
source. In this study, we showed arginine to be sufficient for cell
growth in a growth-limiting medium. Interestingly, the pH of the
medium after 48 hours of growth varied with the initial
composition of the medium. Supplementation of the basal medium
with arginine resulted in an increase of the pH, probably due to a
higher rate of ammonium production via the arginine dihydrolase
pathway. This increase in pH could have deleterious effects on cell
survival in vitro, as suggested by the loss of viability after 120 hours
in the presence of arginine. Moreover, canavanine, a specific
competitive inhibitor of ADI from M. arthritidis [32], suppressed
growth of M. hominis, suggesting that ADI activity is essential for its
growth. For its metabolism, arginine can be transported into M.
hominis cells in its free-form [46]. In our study, arginine was
provided in its free and peptide-bound forms. The free amino-acid
may enter the cell via the putative arginine transporter
(MHO_5040). Additionally, given that there are genes encoding
a putative Opp ABC system (MHO_1510–1550) in the M. hominis
genome, arginine-containing oligopeptides should be considered
as possible alternative source of arginine. Currently, a considerable
limitation on in vivo metabolic studies is the absence of a defined
medium for growing M. hominis. An additional in silico genome-
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help to elucidate the true biochemical capacity of M. hominis,a s
recently described for M. genitalium [48].
We identified a gene encoding a putative DDAH, an enzyme
structurally related to ADI, in the M. hominis PG21 genome. This
suggests that a secondary citrulline-producing pathway, involving
the catalytic conversion of ADMA, may occur in M. hominis.
However, addition of a maximum soluble concentration of ADMA
to a medium supplemented with canavanine was not sufficient to
promote detectable growth. The ADMA concentration was
probably not high enough in our experiments to allow a significant
increase in bacterial cell concentration. Thus, the potential
production of additional citrulline through metabolism of ADMA
in M. hominis remains uncertain but cannot be excluded. ADMA is
naturally present in biological fluids and inhibits nitric oxide
synthase in humans [49]. As previously reported for P. aeruginosa
[50], production of DDAH by M. hominis could indirectly increase
host NO production leading to tissue damage. Consistent with this
hypothesis, M. hominis can stimulate nitric oxide synthase
production by host macrophages [51]. It should also be noted
that the DDAH gene found in M. hominis and its truncated
ortholog found in the closely related M. arthritidis may have been
acquired by HGT from non-mollicute bacterial species, notably
from A. vaginae which belongs to the same urogenital niche than M.
hominis and is also involved in bacterial vaginosis [52].
The arginine utilization pathway may have implications for the
relationship between M. hominis and its host through ammonia
formation. This compound is also generated during the hydrolysis
of urea in U. parvum. As both species are mainly found in the acidic
female genital tract, these pathways could be required to protect
them from the deleterious effects of the acidic environment and
may also promote their pathogenicity. Moreover, M. hominis may
be able to form biofilms since it was identified in microbial biofilms
involved in intraamniotic infection [53]. The ADI pathway may
therefore also play a role in biofilm formation, as previously
suggested for Staphylococcus aureus [54]. Indeed, in S. aureus, the
expression levels of the deiminase pathway were higher in biofilm
cells than in planktonic cells.
To identify a minimal gene set essential for cell viability, Glass et
al. used a global transposon mutagenesis strategy in M. genitalium.
They found 382 of the 482 protein-coding genes to be essential
under laboratory conditions [6]. However, when the 537 M.
hominis protein-coding genes were compared with this set, 147
(38%) were absent from the M. hominis genome (data not shown).
These 147 genes absent from M. hominis mainly encoded proteins
involved in carbohydrate transport and metabolism (PtsH, PtsG,
PtsI, 6-phosphofructokinase, glycerol kinase, pyruvate dehydroge-
nase complex) or in cytadherence and virulence (MgPa, MgpC,
P32, P200, cytadherence accessory proteins Hmw1, 2 and 3). It is
therefore possible that at least two whole gene sets involved in
cytadherence/virulence and in energy-generating carbohydrate
metabolism may be replaced by two other whole gene sets
facilitating similar functions in another minimal species (Figure 1B).
Thus, it is possible that a complete set of genes constituting an
effective energetic pathway, rather than an isolated gene, should
be considered essential. This notion can be extended to the
adhesion/virulence gene set, as most of the M. genitalium adhesion/
virulence genes have been demonstrated to be essential [6].
Consequently, in M. hominis, in addition to the 247 core CDSs
shared by the three minimal species infecting humans, the energy-
generating gene set would mainly consist of the three genes of the
arginine deiminase pathway and the DDAH-encoding gene.
However, the phosphopentomutase- (MHO_4170) and the
phosphoketolase- (MHO_3010) genes, which are specific to M.
hominis, and three genes absent from the core genome but present
in M. hominis and in one other species (encoding glucose 6-
phosphate isomerase, lactate dehydrogenase and glycerol 3-
phosphate dehydrogenase) (Figure 1B) should be added to this
set of energy-providing genes, as they may be required for optimal
energy metabolism in M. hominis. Thus, a minimal mycoplasma
cell, not including cytadherence and virulence-related factors,
could be envisaged to have the 247 gene core genome plus a set of
genes involved in energy production but not already in the core.
This set would include at least nine genes in M. hominis, given that
the genes encoding putative transporters of arginine or sn-glycerol
3-phosphate have not been clearly identified. Thus, in M. hominis,
this would result in a theoretical minimal genome of 256 (247+9)
genes. This gene list could be useful for the synthesis of artificial
genomes using the recently reported complete chemical synthesis
procedure [7,8].
In conclusion, M. hominis PG21 has the second smallest genome
among self-replicating free-living organisms. This species hydro-
lyses arginine as its major energy-source and possesses its own set
of cell-surface proteins as the basis of its urogenital pathogenicity.
We have described a 247 gene core genome based on whole
genome comparisons between M. hominis and the two other human
urogenital pathogens with minimal genomes, M. genitalium and U.
parvum. An additional set of nine genes may be required for the
energy generation in M. hominis. Moreover, a set of 220 M. hominis-
specific genes were identified, which may harbor unknown
virulence genes.
Materials and Methods
Mycoplasma strain
The M. hominis type strain PG21 (ATCC 23114) was chosen and
grown in Hayflick modified medium supplemented with arginine
[43]. Genomic DNA was isolated as previously described [55].
DNA sequencing, sequence assembly, and gap closure
We constructed three libraries to determine the complete
sequence of the M. hominis PG21 genome. For plasmid libraries,
genomic DNA was mechanically sheared and 3 kb fragments were
cloned into pNAV(A) and pCNS vectors (B) (derived from
pcDNA2.1 and pSU18, respectively). Large inserts (25 kb),
generated by HindIII partial digestion, were introduced into
pBeloBac11 (New England Biolabs, Ipswich, USA) (C). Vector
DNA was purified and end-sequenced using dye-terminator
chemistry on ABI3730 sequencers (13440, 8109 and 2304 reads
for library A, B and C, respectively). The Phred/Phrap/Consed
software package (www.phrap.com) was used for the sequence
assembly. A complement of 91 sequences was needed for gap
closure and quality assessment.
Identification of genetic elements and annotation
The genome annotation was performed using the CAAT-Box
platform [56], extended with different tools to facilitate the
annotation process, as previously described [34]. Briefly, CDSs
were detected with the trained GeneMark software [57],
implemented in CAAT-Box, which also integrated results of
BLAST searches [58] in three databases — SwissProt (http://
www.ebi.ac.uk/swissprot/index.html), TrEMBL (http://www.ebi.
ac.uk/embl/index.html), and MolliGen (http://cbi.labri.fr/outils/
molligen/). Sequence similarity and start codons were determined
as previously described [34]. Predicted proteins with similarity
lower than 40% or with only local similarities with previously
characterized proteins were annotated as hypothetical proteins.
Small CDSs or gene fragments were systematically searched for in
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annotation of each CDS was manually verified by at least two
annotators. The tRNA genes were identified as previously
described [34] and the rRNA genes were mapped onto the
chromosome using previously published sequences [10,55].
Lipoproteins were predicted using the PROSITE prokaryotic
membrane lipoprotein lipid attachment site motif (PROKAR_LI-
POPROTEIN).
Detection of Horizontal Gene Transfers in the M. hominis
genome
Putative HGTs were identified as previously described [34].
Briefly, BBHs were identified for every predicted protein using a
BLASTP threshold E-value of 10
28. CDSs displaying a BBH from
a species not belonging to the Hominis phylogenetic group were
further investigated by phylogenetic analyses. Protein phylogenies
were determined using the MEGA4 package [59]. Trees were
constructed using the distance/neighbor-joining method and the
gap complete deletion option; bootstrap statistical analyses were
performed with 500 replicates. Bootstrap values lower than 90%
were not considered significant. Incongruence between protein
and species phylogenies, supported by significant bootstrap values,
was considered to be a potential HGT. Genes for which only very
few homologs were identified or with branches only supported by
low bootstrap values, were not considered to have undergone
HGT unless other independent results suggested otherwise.
Independent results indicative of the occurrence of HGT were a
particularly high similarity value (.80%) and/or conservation of
gene synteny.
Genome analysis and comparisons
Genome analysis and comparisons were conducted using
MolliGen, a database dedicated to the mollicute genomes [60].
Orthologous genes in M. hominis PG21, M. genitalium G37 and U.
parvum serovar 3 (ATCC 700970) were determined using the bi-
directional best hit method followed by manual curation.
Growth of M. hominis PG21 in the presence of arginine
and arginine analogs
M. hominis PG21 was grown in a basal medium containing heart
infusion broth (Difco), yeast extract (Bio-Rad), and 2.5% horse
serum (Difco), with or without 10 mM arginine (Fluka), 10 mM
canavanine (Sigma) or 0.5 mM N
v,N
v-dimethyl-L-arginine
(ADMA) (Sigma) in 4% dimethylsufoxide, individually or in
combination. Identical experiments were conducted with a basal
medium without horse serum to limit the arginine content. The
pH of the media was adjusted to 7 before inoculation with M.
hominis. The initial free arginine concentration of 2.5% serum-
containing Hayflick media was measured at 1.4 mM by HPLC
(High Performance Liquid Chromatography) after deproteinisa-
tion. Incubation time was 48 and 120 hours and growth was
measured in CCU per ml [43]. At t=0, 48 and 120 hours, 100 ml
of culture was diluted to generate a tenfold dilution series to 10
212
in Hayflick modified broth medium supplemented with 23 mM
arginine. Results are the means of at least three independent
experiments.
Database submission and web-accessible database
The genome sequence and related features of the M. hominis
PG21 strain were submitted to the EMBL/GenBank/DDBJ
databases under accession number FP236530. All data are also
available from the MolliGen database (http://cbib1.cbib.
u-bordeaux2.fr/outils/molligen/home.php).
Supporting Information
Figure S1 Analysis of the M.hominis genomic region
MHO_0120-MHO_0140. (A) Schematic of the homologous
genomic regions encoding a Type III restriction-modification
system in U. parvum (UU), M. hominis (MHO), and M. pulmonis
(MYPU). Homologous genes are connected by dashed lines. (B)
Partial amino acid and nucleotide multiple alignments corre-
sponding to the C-terminal region of MHO_0140. Repeats that
may be involved in phase variation are written in blue; stop codons
are in red. (C) Phylogenetic tree inferred from amino acid
sequences of the restriction component of the systems. Bootstrap
values are indicated on nodes. MAG, M. agalactiae; MHP7448, M.
hyopneumoniae 7448; mhp, M. hyopneumoniae 232; MHJ, M.
hyopneumoniae J; MYPU, M. pulmonis; MYPE, M. penetrans; MMOB,
M. mobile. Numbers after the strain name indicate mnemonics.
Found at: doi:10.1371/journal.pgen.1000677.s001 (0.87 MB TIF)
Figure S2 Analysis of the M. hominis genomic regions
MHO_3220-MHO_3250 and MHO_5210-MHO_5240 encod-
ing Type I restriction-modification systems. (A) Schematic of the
homologous genomic regions in U. parvum (UU) and M. hominis
(MHO). Homologous genes are connected by dashed lines; the
locus is recombined in U. parvum. Phylogenetic trees inferred from
amino acid sequences of the MHO_5230 homologs (S subunit)
and MHO_5210 homologs (M subunit) are presented in (B) and
(C), respectively. Bootstrap values are indicated on nodes. MPN,
M. pneumoniae; MAG, M. agalactiae; SPICI, Spiroplasma citri; MGA,
M. gallisepticum; MYPU, M. pulmonis; MMOB, M. mobile. Numbers
after the strain name indicate mnemonics.
Found at: doi:10.1371/journal.pgen.1000677.s002 (0.71 MB TIF)
Figure S3 Analysis of the M. hominis genomic region
MHO_2520-MHO_2530. (A) Schematic of the homologous
genomic regions encoding IS1138 transposase gene in U. parvum
(UU), M. hominis (MHO) and M. pulmonis (MYPU). The
transposase encoding gene is fragmented in M. hominis and U.
parvum. (B) Partial nucleotide alignment showing the nearly
identical sequences of MHO_2530, MHO_2560, and UU372.
(C) Phylogenetic tree inferred from amino acid sequences of the
IS1138 transposases. Bootstrap values are indicated on nodes.
MSC, M. mycoides subsp. mycoides SC; SPICI, S. citri; AYWB, ca.
Phytoplasma asteris Aster Yellows Witches Broom; PAM, ca.
Phytoplasma asteris Onion Yellows. Numbers after the strain
name indicate mnemonics.
Found at: doi:10.1371/journal.pgen.1000677.s003 (0.83 MB TIF)
Figure S4 Analysis of the M. hominis genomic region
MHO_3120-MHO_3200. (A) Schematic of the homologous
genomic regions in U. parvum (UU) and M. hominis (MHO).
Homologous genes are connected by dashed lines. Phylogenetic
trees inferred from amino acid sequences of the MHO_3120
homologs and MHO_3200 homologs are presented in (B) and (C),
respectively. Bootstrap values are indicated on nodes. MSC, M.
mycoides subsp. mycoides SC; MCAP, M. capricolum subsp. capricolum;
MAG, M. agalactiae; mhp, M. hyopneumoniae; MGA, M. gallisepticum;
MYPU, M. pulmonis; MS53, M. synoviae; MMOB, M. mobile.
Numbers after the strain name indicate mnemonics.
Found at: doi:10.1371/journal.pgen.1000677.s004 (0.73 MB TIF)
Table S1 Orthology between the genomes of M. hominis, M.
genitalium and U. parvum. These data are presented in an excel file
to facilitate analysis. Orthology was determined using a bidirec-
tional best hit method, followed by manual curation. The columns
are as follows: (A) M. hominis gene locus (mnemonic); (B) M. hominis
gene name; (C) M. hominis gene product; (D) M. genitalium gene
locus (mnemonic); (E) M. genitalium gene name; (F) M. genitalium
Mycoplasma Minimal Genomes
PLoS Genetics | www.plosgenetics.org 11 October 2009 | Volume 5 | Issue 10 | e1000677gene product; (G) U. parvum gene locus (mnemonic); (H) U. parvum
gene name; (I) U. parvum gene product.
Found at: doi:10.1371/journal.pgen.1000677.s005 (0.21 MB
XLS)
Table S2 The 247 genes shared by M. hominis, M. genitalium and
U. parvum:transposon insertions in orthologs from M. pulmonis, M.
arthritidis, and M. genitalium and orthologs in other human and
animal mycoplasma sequenced genomes. The columns are as
follows: (A) Gene name, (B) Product, (C) Locus in M. hominis PG21
(mnemonic), (D) Locus in M. genitalium G37 [3] (mnemonic), (E)
Locus in U. parvum serovar 3 [11] (mnemonic), (F) Transposon
insertion in ortholog from M. pulmonis according to [19], (G)
Transposon insertion in ortholog from M. arthritidis according to
[13], (H) Transposon insertion in ortholog from M. genitalium
according to [6], (I–U) Predicted orthologs in other human and
animal mycoplasma sequenced genomes, M. capricolum subsp.
capricolum, M. mycoides subsp. mycoides SC, M. gallisepticum, M.
genitalium, M. pneumoniae, M. penetrans, U. parvum, M. agalactiae, M.
arthritidis, M. hyopneumoniae 232, M. mobile, M. pulmonis, M. synoviae,
respectively. (V) Presence in all species.
Found at: doi:10.1371/journal.pgen.1000677.s006 (0.16 MB
XLS)
Acknowledgments
We thank Matt De Jongh for helpful discussion, as well as Claire Lemaı ˆtre
and Patricia The ´bault for orthology relationship prediction. We are
indebted to Didier Raoult and Michel Drancourt for their helpful
discussion and support to submit our project to the French National
Sequencing Center, Genoscope. We thank Christiane Be ´be ´ar for critical
reading of the manuscript.
Author Contributions
Conceived and designed the experiments: SP PSP LB AB CMB.
Performed the experiments: SP PSP LB AC HR PA AC VB CMB.
Analyzed the data: SP PSP LB AC HR PA AB CMB. Contributed
reagents/materials/analysis tools: AB DJ AdD. Wrote the paper: SP PSP
LB AB CMB.
References
1. Waites K, Talkington D (2005) New developments in human diseases due to
mycoplasmas. In: Blanchard A, Browning GF, eds. Mycoplasmas molecular
biology pathogenicity and strategies for control. Norfolk: Horizon bioscience. pp
289–354.
2. Robertson JA, Stemke GW, Davis JW, Jr., Harasawa R, Thirkell D, et al. (2002)
Proposal of Ureaplasma parvum sp. nov. and emended description of Ureaplasma
urealyticum (Shepard et al. 1974) Robertson et al. 2001. Int J Syst Evol Microbiol
52: 587–597.
3. Fraser CM, Gocayne JD, White O, Adams MD, Clayton RA, et al. (1995) The
minimal gene complement of Mycoplasma genitalium. Science 270: 397–403.
4. Hutchison CA, Peterson SN, Gill SR, Cline RT, White O, et al. (1999) Global
transposon mutagenesis and a minimal mycoplasma genome. Science 286:
2165–2169.
5. Mushegian AR, Koonin EV (1996) A minimal gene set for cellular life derived
by comparison of complete bacterial genomes. Proc Natl Acad Sci U S A 93:
10268–10273.
6. Glass JI, Assad-Garcia N, Alperovich N, Yooseph S, Lewis MR, et al. (2006)
Essential genes of a minimal bacterium. Proc Natl Acad Sci U S A 103:
425–430.
7. Gibson DG, Benders GA, Andrews-Pfannkoch C, Denisova EA, Baden-
Tillson H, et al. (2008) Complete chemical synthesis, assembly, and cloning of
a Mycoplasma genitalium genome. Science 319: 1215–1220.
8. Gibson DG, Benders GA, Axelrod KC, Zaveri J, Algire MA, et al. (2008) One-
step assembly in yeast of 25 overlapping DNA fragments to form a complete
synthetic Mycoplasma genitalium genome. Proc Natl Acad Sci U S A 105:
20404–20409.
9. Endy D (2008) Genomics. Reconstruction of the genomes. Science 319:
1196–1197.
10. Ladefoged SA, Christiansen G (1992) Physical and genetic mapping of the
genomes of five Mycoplasma hominis strains by pulsed-field gel electrophoresis.
J Bacteriol 174: 2199–2207.
11. Glass JI, Lefkowitz EJ, Glass JS, Heiner CR, Chen EY, et al. (2000) The
complete sequence of the mucosal pathogen Ureaplasma urealyticum. Nature 407:
757–762.
12. Pollack JD (1992) Carbohydrate metabolism and energy conservation. In:
Maniloff J, ed. Mycoplasmas: molecular biology and pathogenesis. Washington,
D.C.: American Society for Microbiology. pp 181–200.
13. Dybvig K, Zuhua C, Lao P, Jordan DS, French CT, et al. (2008) Genome of
Mycoplasma arthritidis. Infect Immun 76: 4000–4008.
14. Lartigue C, Blanchard A, Renaudin J, Thiaucourt F, Sirand-Pugnet P (2003)
Host specificity of mollicutes oriC plasmids: functional analysis of replication
origin. Nucleic Acids Res 31: 6610–6618.
15. Westberg J, Persson A, Holmberg A, Goesmann A, Lundeberg J, et al. (2004)
The genome sequence of Mycoplasma mycoides subsp mycoides SC type strain
PG1(T), the causative agent of contagious bovine pleuropneumonia (CBPP).
Genome Res 14: 221–227.
16. Messer W (2002) The bacterial replication initiator DnaA. DnaA and oriC, the
bacterial mode to initiate DNA replication. FEMS Microbiol Rev 26: 355–374.
17. Jaffe JD, Stange-Thomann N, Smith C, DeCaprio D, Fisher S, et al. (2004) The
complete genome and proteome of Mycoplasma mobile. Genome Res 14:
1447–7461.
18. Dybvig K, Cao Z, French CT, Yu H (2007) Evidence for type III restriction and
modification systems in Mycoplasma pulmonis. J Bacteriol 189: 2197–2202.
19. French CT, Lao P, Loraine AE, Matthews BT, Yu H, et al. (2008) Large-scale
transposon mutagenesis of Mycoplasma pulmonis. Mol Microbiol 69: 67–76.
20. Mardassi BB, Ayari H, Bejaoui-Khiari A, Mlik B, Moalla I, et al. (2007) Genetic
variability of the P1209 surface protein gene of Mycoplasma hominis isolates
recovered from Tunisian patients with uro-genital and infertility disorders. BMC
Infect Dis 7: 142.
21. Ladefoged SA (2000) Molecular dissection of Mycoplasma hominis. APMIS 108:
5–45.
22. Boesen T, Emmersen J, Baczynska A, Birkelund S, Christiansen G (2004) The
vaa locus of Mycoplasma hominis contains a divergent genetic islet encoding a
putative membrane protein. BMC Microbiol 4: 37.
23. Hopfe M, Hoffmann R, Henrich B (2004) P80, the HinT interacting membrane
protein, is a secreted antigen of Mycoplasma hominis. BMC Microbiol 4.
24. Mygind T, Birkelund S, Christiansen G (2000) Characterization of the
variability of a 75-kDa membrane protein in Mycoplasma hominis.F E M S
Microbiol Let 190: 167–176.
25. Hopfe M, Henrich B (2004) OppA, the substrate-binding subunit of the
oligopeptide permease, is the major Ecto-ATPase of Mycoplasma hominis.
J Bacteriol 186: 1021–1028.
26. Henrich B, Hopfe M, Kitzerow A, Hadding U (1999) The adherence-associated
lipoprotein P100, encoded by an opp operon structure, functions as the
oligopeptide-binding domain OppA of a putative oligopeptide transport system
in Mycoplasma hominis. J Bacteriol 181: 4873–4878.
27. Hopfe M, Henrich B (2008) OppA, the ecto-ATPase of Mycoplasma hominis
induces ATP release and cell death in HeLa cells. BMC Microbiol 8: 55.
28. Ladefoged SA, Jensen LT, Brock B, Birkelund S, Christiansen G (1996) Analysis
of 0.5-kilobase-pair repeats in the Mycoplasma hominis lmp gene system and
identification of gene products. J Bacteriol 178: 2775–2784.
29. Dhandayuthapani S, Blaylock MW, Be ´be ´ar CM, Rasmussen WG, Baseman JB
(2001) Peptide methionine sulfoxide reductase (MsrA) is a virulence determinant
in Mycoplasma genitalium. J Bacteriol 183: 5645–5650.
30. Halbedel S, Hames C, Stulke J (2007) Regulation of carbon metabolism in the
mollicutes and its relation to virulence. J Mol Microbiol Biotechnol 12: 147–154.
31. Sasaki Y, Ishikawa J, Yamashita A, Oshima K, Kenri T, et al. (2002) The
complete genomic sequence of Mycoplasma penetrans, an intracellular bacterial
pathogen in humans. Nucleic Acids Res 30: 5293–5300.
32. Smith DW, Ganaway RL, Fahrney DE (1978) Arginine deiminase from
Mycoplasma arthritidis. Structure-activity relationships among substrates and
competitive inhibitors. J Biol Chem 253: 6016–6020.
33. Pine MJ (1978) Comparative physiological effects of incorporated amino acid
analogs in Escherichia coli. Antimicrob Agents Chemother 13: 676–685.
34. Sirand-Pugnet P, Lartigue C, Marenda M, Jacob D, Barre A, et al. (2007) Being
pathogenic, plastic, and sexual while living with a nearly minimal bacterial
genome. PLoS Genet 3: e75. doi:10.1371/journal.pgen.0030075.
35. Andersen B, Sokolowski I, Ostergaard L, Kjolseth Moller J, Olesen F, et al.
(2007) Mycoplasma genitalium: prevalence and behavioural risk factors in the
general population. Sex Transm Infect 83: 237–241.
36. Himmelreich R, Hilbert H, Plagens H, Pirkl E, Li BC, et al. (1996) Complete
sequence analysis of the genome of the bacterium Mycoplasma pneumoniae. Nucleic
Acids Res 24: 4420–4449.
37. Iverson-Cabral SL, Astete SG, Cohen CR, Rocha EP, Totten PA (2006)
Intrastrain heterogeneity of the mgpB gene in Mycoplasma genitalium is extensive in
vitro and in vivo and suggests that variation is generated via recombination with
repetitive chromosomal sequences. Infect Immun 74: 3715–3726.
38. Su CJ, Dallo SF, Chavoya A, Baseman JB (1993) Possible origin of sequence
divergence in the P1 cytadhesin gene of Mycoplasma pneumoniae. Infect Immun 61:
816–822.
Mycoplasma Minimal Genomes
PLoS Genetics | www.plosgenetics.org 12 October 2009 | Volume 5 | Issue 10 | e100067739. Razin S (2006) The genus Mycoplasma and related genera (class Mollicutes). In:
Dworkin M, ed. Procaryotes. New York: Springer. pp 836–904.
40. Barabote RD, Saier MH, Jr. (2005) Comparative genomic analyses of the
bacterial phosphotransferase system. Microbiol Mol Biol Rev 69: 608–634.
41. Vasconcelos AT, Ferreira HB, Bizarro CV, Bonatto SL, Carvalho MO, et al.
(2005) Swine and poultry pathogens: the complete genome sequences of two
strains of Mycoplasma hyopneumoniae and a strain of Mycoplasma synoviae. J Bacteriol
187: 5568–5577.
42. Muhlradt A, Peleg I, Robertson JA, Robinson IM, Kahane I (1981) Acetate
kinase activity in mycoplasmas. J Bacteriol 147: 271–273.
43. Waites KB, Be ´be ´ar CM, Roberston JA, Talkington DF, Kenny GE, eds (2001)
Cumitech 34, Laboratory diagnosis of mycoplasmal infections. Washington
D. C.: American Society for Microbiology.
44. Razin S (1973) Physiology of mycoplasmas. Adv Microb Physiol 10: 1–80.
45. Smith PF (1971) Dynamics of reproduction and growth. In: Inc. AP, ed. Biolo-
gy of mycoplasmas. New York: Sols, A. and G. de la Fuente. pp 99–161.
46. Hahn RG, Kenny GE (1974) Differences in arginine requirement for growth
among arginine-utilizing Mycoplasma species. J Bacteriol 117: 611–618.
47. Fenske JD, Kenny GE (1976) Role of arginine deiminase in growth of
Mycoplasma hominis. J Bacteriol 126: 501–510.
48. Suthers PF, Dasika MS, Kumar VS, Denisov G, Glass JI, et al. (2009) A
genome-scale metabolic reconstruction of Mycoplasma genitalium, iPS189. PLoS
Comput Biol 5: e1000285. doi:10.1371/journal.pcbi.1000285.
49. Stone EM, Person MD, Costello NJ, Fast W (2005) Characterization of a
transient covalent adduct formed during dimethylarginine dimethylaminohy-
drolase catalysis. Biochemistry 44: 7069–7078.
50. Dowling RB, Newton R, Robichaud A, Cole PJ, Barnes PJ, et al. (1998) Effect of
inhibition of nitric oxide synthase on Pseudomonas aeruginosa infection of
respiratory mucosa in vitro. Am J Respir Cell Mol Biol 19: 950–958.
51. Crouse DT, English BK, Livingston L, Meals EA (1998) Genital mycoplasmas
stimulate tumor necrosis factor-alpha and inducible nitric oxide synthase
production from a murine macrophage cell line. Pediatr Res 44: 785–790.
52. Bradshaw CS, Tabrizi SN, Fairley CK, Morton AN, Rudland E, et al. (2006)
The association of Atopobium vaginae and Gardnerella vaginalis with bacterial
vaginosis and recurrence after oral metronidazole therapy. J Infect Dis 194:
828–836.
53. Romero R, Schaudinn C, Kusanovic JP, Gorur A, Gotsch F, et al. (2008)
Detection of a microbial biofilm in intraamniotic infection. Am J Obstet Gynecol
198: 135 e131–135.
54. Resch A, Rosenstein R, Nerz C, Gotz F (2005) Differential gene expression
profiling of Staphylococcus aureus cultivated under biofilm and planktonic
conditions. Appl Environ Microbiol 71: 2663–2676.
55. Pereyre S, Gonzalez P, de Barbeyrac B, Darnige A, Renaudin H, et al. (2002)
Mutations in 23S rRNA account for intrinsic resistance to macrolides in
Mycoplasma hominis and Mycoplasma fermentans and for acquired resistance to
macrolides in M. hominis. Antimicrob Agents Chemother 46: 3142–3150.
56. Frangeul L, Glaser P, Rusniok C, Buchrieser C, Duchaud E, et al. (2004)
CAAT-Box, Contigs-Assembly and Annotation Tool-Box for genome sequenc-
ing projects. Bioinformatics 20: 790–797.
57. Isono K, McIninch JD, Borodovsky M (1994) Characteristic features of the
nucleotide sequences of yeast mitochondrial ribosomal protein genes as analyzed
by computer program GeneMark. DNA Res 1: 263–269.
58. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ (1990) Basic local
alignment search tool. J Mol Biol 215: 403–410.
59. Tamura K, Dudley J, Nei M, Kumar S (2007) MEGA4: Molecular Evolutionary
Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 24: 1596–1599.
60. Barre ´ A, de Daruvar A, Blanchard A (2004) MolliGen, a database dedicated
to the comparative genomics of Mollicutes. Nucleic Acids Res 32 Database
issue: D307–D310.
Mycoplasma Minimal Genomes
PLoS Genetics | www.plosgenetics.org 13 October 2009 | Volume 5 | Issue 10 | e1000677